Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03836781Phase 3Completed
Phase 3, randomised, open-label trial of ketorolac in chronic periodontitis (2 arms). Primary endpoint: Pocket Depth at 3 months. Started Apr 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03836781.